Public signalCompany raiseAuto-indexed · Unverified
Renibus Therapeutics, Inc. raised $110.9M
Renibus Therapeutics, Inc.· SOUTHLAKE, US· Pharmaceuticals· Filed Jul 17, 2025
Renibus Therapeutics, Inc. reported raising capital. Based in SOUTHLAKE, TEXAS, US. First sale reported 2023-05-25. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.
Raised
$110.9M
Confidence90%
On the record
- Location
- SOUTHLAKE, US
- Sector
- Pharmaceuticals
- Record type
- Company raise
- Stage
- Reported raised
- Amount raised
- $110.9M
- Target amount
- $110.9M
- Filing date
- Jul 17, 2025
- Issuer type
- operating company
Gaps in the record
- Valuation and deal terms are not on the public record
- No company website on record
- Investors are not disclosed
- Not yet claimed or verified by the company
Sources & provenance
“Operating company sold 110,895,239 USD under Reg D.”
View original filing (SEC EDGAR Form D)
Automatically indexed from SEC EDGAR Form D · filing dated Jul 17, 2025. Details beyond the filing have not been verified.
Tags
AmendmentUSCompanyPharmaceuticalsOver $100MCompany Raise
Are you associated with Renibus Therapeutics, Inc.?
This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.
Claim this record